Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin D Humphreys

Showing results (191-200 of 223) with videos related to

Pageof 23
Sort By:
Journal of the American Society of Nephrology : JASN|March 1, 2023
Tubular Epithelial Cell HMGB1 Promotes AKI-CKD Transition by Sensitizing Cycling Tubular Cells to Oxidative Stress: A Rationale for Targeting HMGB1 during AKI RecoveryZhi Bo Zhao, Julian A Marschner, Takamasa Iwakura, et al.
Cell Stem Cell|September 13, 2016
Adventitial MSC-like Cells Are Progenitors of Vascular Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney DiseaseRafael Kramann, Claudia Goettsch, Janewit Wongboonsin, et al.
The Journal of Clinical Investigation|August 28, 2013
Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosisBenjamin D Humphreys, Fengfeng Xu, Venkata Sabbisetti, et al.
Nature Communications|April 19, 2023
Mapping genomic regulation of kidney disease and traits through high-resolution and interpretable eQTLsSeong Kyu Han, Michelle T McNulty, Christopher J Benway, et al.
Iscience|April 14, 2025
Injured tubular epithelia-derived CCN1 promotes the mobilization of fibroblasts toward injury sites after kidney injuryTomohiro Nakata, Yuhei Kirita, Minato Umehara, et al.
Kidney International|March 11, 2022
Kidney repair and regeneration: perspectives of the NIDDK (Re)Building a Kidney consortiumBilal A Naved, Joseph V Bonventre, Jeffrey A Hubbell, et al.
JIMD Reports|November 15, 2024
Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L <i>GATM</i> variant and study of organoids towards treatmentIgnacio Portales-Castillo, Rhea Singal, Anastasia Ambrose, et al.
JCI Insight|October 22, 2024
Circulating proteins linked to apoptosis processes and fast development of end-stage kidney disease in diabetesKatsuhito Ihara, Eiichiro Satake, Parker C Wilson, et al.
Scientific Reports|August 14, 2025
Genetic deletion of the sodium phosphate cotransporter NaPi2a ameliorates heart failure in miceHiroko Yamauchi-Sawada, Tomoharu Ida, Masashi Nakamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancerUrsula A Matulonis, Suzanne Berlin, Percy Ivy, et al.
Pageof 23

Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
Journal of the American Society of Nephrology : JASN|March 1, 2023
Tubular Epithelial Cell HMGB1 Promotes AKI-CKD Transition by Sensitizing Cycling Tubular Cells to Oxidative Stress: A Rationale for Targeting HMGB1 during AKI RecoveryZhi Bo Zhao, Julian A Marschner, Takamasa Iwakura, et al.
Cell Stem Cell|September 13, 2016
Adventitial MSC-like Cells Are Progenitors of Vascular Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney DiseaseRafael Kramann, Claudia Goettsch, Janewit Wongboonsin, et al.
The Journal of Clinical Investigation|August 28, 2013
Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosisBenjamin D Humphreys, Fengfeng Xu, Venkata Sabbisetti, et al.
Nature Communications|April 19, 2023
Mapping genomic regulation of kidney disease and traits through high-resolution and interpretable eQTLsSeong Kyu Han, Michelle T McNulty, Christopher J Benway, et al.
Iscience|April 14, 2025
Injured tubular epithelia-derived CCN1 promotes the mobilization of fibroblasts toward injury sites after kidney injuryTomohiro Nakata, Yuhei Kirita, Minato Umehara, et al.
Kidney International|March 11, 2022
Kidney repair and regeneration: perspectives of the NIDDK (Re)Building a Kidney consortiumBilal A Naved, Joseph V Bonventre, Jeffrey A Hubbell, et al.
JIMD Reports|November 15, 2024
Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L <i>GATM</i> variant and study of organoids towards treatmentIgnacio Portales-Castillo, Rhea Singal, Anastasia Ambrose, et al.
JCI Insight|October 22, 2024
Circulating proteins linked to apoptosis processes and fast development of end-stage kidney disease in diabetesKatsuhito Ihara, Eiichiro Satake, Parker C Wilson, et al.
Scientific Reports|August 14, 2025
Genetic deletion of the sodium phosphate cotransporter NaPi2a ameliorates heart failure in miceHiroko Yamauchi-Sawada, Tomoharu Ida, Masashi Nakamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancerUrsula A Matulonis, Suzanne Berlin, Percy Ivy, et al.
Pageof 23